FDA Inspection
SGS North America IncSGS North America Inc – FDA Inspection, May 8, 2024
Record Details
This FDA Inspection record concerns SGS North America Inc, with an inspection on May 8, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 2948dad6-d9c5-4c63-9147-304152e6a28d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1239166
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of SGS North America Inc
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 23, 2017 | VAI | Center for Drug Evaluation and Research | Generic Drug Evaluation |
Other documents for SGS North America Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.